The future of fusion gene detection lies in the integration of precision medicine. Advances in sequencing technologies and bioinformatics will enable more accurate and cost-effective detection methods. Additionally, the development of universal diagnostic platforms could streamline the process, making fusion gene detection a routine part of cancer diagnostics.
